ENDRA Life Sciences (NDRA) Return on Assets (2017 - 2026)

ENDRA Life Sciences (NDRA) has reported Return on Assets for 10 consecutive years, with 0.02% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Assets rose 3.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (up 3.0% YoY), while the FY2025 annual figure was 0.03%, changed 0.0% from the prior year.
• Return on Assets improved to 0.02% in Q1 2026 per NDRA's latest filing, from 0.03% in the prior quarter.
• Across five years, Return on Assets topped out at 0.01% in Q2 2022 and bottomed at 0.26% in Q4 2024.
• Historically, Return on Assets has averaged 0.03% across 5 years, with a median of 0.02% in 2024.
• Annual changes were most pronounced in 2024 — Return on Assets slipped 25 bps — and 2025, when it rose 23 bps.
• ENDRA Life Sciences' Return on Assets stood at 0.01% in 2022, then declined by 15 bps to 0.01% in 2023, then slumped by 1788 bps to 0.26% in 2024, then soared by 88 bps to 0.03% in 2025, then soared by 38 bps to 0.02% in 2026.
• Business Quant data shows NDRA's Return on Assets at 0.02% in Q1 2026, 0.03% in Q4 2025, and 0.04% in Q3 2025.